Background illustration for clinical trials search

Paid Clinical Trials Los Angeles

Discover 3,550 paid clinical trials in Los Angeles, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation

for
Advanced Solid Tumor, Unresectable Solid Tumor,
Location: Los Angeles CA, San Francisco CA, Sacramento CA,
Sponsor: Clasp Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06778863

Phase1, Recruiting

Breast Cancer Survivorship Biorepository

for
Anatomic Stage I Breast Cancer AJCC v8,
Location: Los Angeles CA
Sponsor: University of Southern California

Sex: Female

Age: 18+

Code: NCT05786664

Recruiting

A Study Investigating BGB-26808 Alone or in Combination With Tislelizumab in Participants With Advanced Solid Tumors

for
Advanced Solid Tumor, Solid Tumor
Location: Los Angeles CA, Duarte CA, Portland OR, Houston TX,
Sponsor: BeOne Medicines

Sex: All

Age: 18+

Code: NCT05981703

Phase1, Recruiting

A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors

for
Advanced Cancer, Metastatic Cancer, Ovarian Cancer,
Location: Los Angeles CA, Santa Barbara CA, Scottsdale AZ,
Sponsor: Artios Pharma Ltd

Sex: All

Age: 18+

Code: NCT04657068

Phase1, Phase2, Recruiting

MSC EVs in Dystrophic Epidermolysis Bullosa

for
Dystrophic Epidermolysis Bullosa
Location: Los Angeles CA, Phoenix AZ, Philadelphia PA
Sponsor: Aegle Therapeutics

Sex: All

Age: 0+

Code: NCT04173650

Phase1, Phase2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Study to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With Pembrolizumab Alone in Participants With Untreated Advanced Melanoma.

for
Metastatic Melanoma, Unresectable Melanoma, Melanoma
Location: Los Angeles CA, Duarte CA, San Francisco CA,
Sponsor: Iovance Biotherapeutics, Inc.

Sex: All

Age: 18 - 70

Code: NCT05727904

Phase3, Recruiting

SW-682 in Advanced Solid Tumors

for
Advanced Solid Tumor, Mesothelioma, Malignant
Location: Los Angeles CA, Santa Monica CA, Sacramento CA,
Sponsor: SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany

Sex: All

Age: 18+

Code: NCT06251310

Phase1, Recruiting

Safety and Tolerability Study of GIM-122 in Subjects With Advanced Solid Malignancies

for
Advanced Solid Malignancies
Location: Los Angeles CA, San Francisco CA, Irving TX, Dallas TX,
Sponsor: Georgiamune Inc

Sex: All

Age: 18+

Code: NCT06028074

Phase1, Phase2, Recruiting

A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study)

for
Small Cell Lung Cancer (SCLC),
Location: Los Angeles CA, Duarte CA, Portland OR, Seattle WA,
Sponsor: Phanes Therapeutics

Sex: All

Age: 18+

Code: NCT05652686

Phase1, Phase2, Recruiting

A Phase 1 Study of CPO301 in Adult Patients With Advanced or Metastatic Solid Tumors

for
Cancer, Cancer, Lung
Location: Los Angeles CA, Santa Monica CA, Newport Beach CA,
Sponsor: Conjupro Biotherapeutics, Inc.

Sex: All

Age: 18+

Code: NCT05948865

Phase1, Recruiting

Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Tuspetinib (HM43239) in Patients With Relapsed or Refractory Acute Myeloid Leukemia

for
Leukemia, Myeloid, Acute, Refractory AML, Relapsed Adult AML,
Location: Los Angeles CA, Irvine CA, Palo Alto CA, Sacramento CA,
Sponsor: Aptose Biosciences Inc.

Sex: All

Age: 18+

Code: NCT03850574

Phase1, Phase2, Recruiting

CRISPR-Edited Allogeneic Anti-CD19 CAR-T Cell Therapy for Relapsed/Refractory B Cell Non-Hodgkin Lymphoma (ANTLER)

for
Lymphoma, Non-Hodgkin, Relapsed Non Hodgkin Lymphoma,
Location: Los Angeles CA, Orange CA, La Jolla CA, Scottsdale AZ,
Sponsor: Caribou Biosciences, Inc.

Sex: All

Age: 18+

Code: NCT04637763

Phase1, Recruiting

A Tissue Collection Study in Patients Who Respond to Immune Checkpoint Inhibitors to Identify Targets of Tumor-Reactive T Cells.

for
Solid Tumor, Adult
Location: Los Angeles CA, New Orleans LA, Morristown NJ,
Sponsor: TScan Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT05230186

Recruiting

A Study to Investigate Safety and Effectiveness of Tacabrutideg (BGB-16673) in Combination With Other Agents in Participants With Relapsed or Refractory B-Cell Malignancies

for
B-cell Malignancy, Relapsed Cancer, Refractory Cancer,
Location: Los Angeles CA, Phoenix AZ, Salt Lake City UT,
Sponsor: BeOne Medicines

Sex: All

Age: 18+

Code: NCT06634589

Phase1, Phase2, Recruiting

A First-In Human (FIH) Study to Find Out How Well REGN10597 Medicine Given Alone or in Combination With Cemiplimab Works in Adult Participants Who Have Cancer With Tumors That Have Spread in Their Body

for
Melanoma, Clear-Cell Renal-Cell Carcinoma (ccRCC),
Location: Los Angeles CA, San Francisco CA, San Antonio TX,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT06413680

Phase1, Phase2, Recruiting

A Study Comparing the Efficacy and Safety of Zanidatamab to Trastuzumab, Each in Combination With Physician's Choice Chemotherapy, for the Treatment of Participants With Metastatic HER2-positive Breast Cancer

for
Metastatic HER2-positive Breast Cancer
Location: Los Angeles CA, Glendale CA, Cerritos CA,
Sponsor: Jazz Pharmaceuticals

Sex: All

Age: 18+

Code: NCT06435429

Phase3, Recruiting

LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve

for
Superficial Bladder Cancer,
Location: Los Angeles CA, Irvine CA, San Diego CA, La Jolla CA,
Sponsor: enGene, Inc.

Sex: All

Age: 18+

Code: NCT04752722

Phase1, Phase2, Recruiting

Ivosidenib Plus Durvalumab and Gemcitabine/Cisplatin as First-Line Therapy in Participants With Locally Advanced or Metastatic Cholangiocarcinoma With an IDH1 Mutation

for
Locally Advanced, Unresectable or Metastatic Cholangiocarcinoma With an IDH1 Mutation,
Location: Los Angeles CA, Los Alamitos CA, Houston TX, Chicago IL,
Sponsor: Institut de Recherches Internationales Servier

Sex: All

Age: 18+

Code: NCT06501625

Phase1, Phase2, Recruiting

A Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants With Bladder Cancer

for
Non-Muscle Invasive Bladder Cancer
Location: Los Angeles CA, Orange CA, San Diego CA, Lakewood CO,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT06319820

Phase3, Recruiting

A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)

for
Urinary Bladder Neoplasms,
Location: Los Angeles CA, Torrance CA, Bakersfield CA,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06833073

Phase2, Recruiting

With a vast healthcare network and top-tier medical research centers, Los Angeles is a key hub for a wide range of clinical trials. Renowned institutions such as UCLA Health, Cedars-Sinai Medical Center, and the Keck School of Medicine at USC lead pioneering research across various fields, including cancer, cardiovascular health, and neuroscience.

Many Los Angeles medical centers are at the forefront of innovative studies, positioning the city as a critical location for advancing medical research and improving patient care outcomes.

Why choose Los Angeles for clinical trials?

Los Angeles offers distinct advantages for individuals participating in clinical trials. The city’s diverse population provides a wide range of participants, enhancing the accuracy and applicability of research findings across different demographics.

Known for its forward-thinking research environment, Los Angeles is home to leading institutions that drive cutting-edge studies in a variety of medical fields. By choosing to participate in a clinical trial in Los Angeles, individuals contribute to groundbreaking medical research while benefiting from the city's well-established clinical research infrastructure and access to world-class healthcare professionals.

Common conditions studied in Los Angeles

Local regulations and guidelines

Benefits of participating in clinical trials

How to enroll in a clinical trial in Los Angeles